Citation map · Study

SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Despite Criticism Of The FDA Review Process, New Cancer Drugs Reach Patients Sooner In The United States Than In Europe

4 references·3 citing·30 second hop

FromToDepth

this work references cited by second hop

References

2014Reputation and Power862 cited
2007Economics of New Oncology Drug Development348 cited
2010Pharmaceutical Innovation in the 21st Century: New Drug Approvals in the First Decade, 2000–2009329 cited
2006Reimbursement for Cancer Treatment: Coverage of Off-Label Drug Indications81 cited

Cited by

2022Comparison of Cancer-Related Spending and Mortality Rates in the US vs 21 High-Income Countries62 cited
2016Patient-Reported Outcomes Labeling for Products Approved by the Office of Hematology and Oncology Products of the US Food and Drug Administration (2010-2014)58 cited
2015Use of the conditional marketing authorization pathway for oncology medicines in Europe57 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work